Track topics on Twitter Track topics that are important to you
The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...
At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...
(University of Oklahoma) A University of Oklahoma and Mercy Hospital Oklahoma City research team is set to begin the largest breast cancer clinical trial ever performed in Oklahoma. The team has devel...
A new study published in Clinical Breast Cancer demonstrates that Videssa® Breast, a multi-protein biomarker blood test to detect breast cancer, can help inform better decision-making after abnormal ...
(Provista Diagnostics) Clinical Breast Cancer study demonstrates Videssa Breast can inform better next steps after abnormal mammogram results & potentially reduce biopsies up to 67%.
Noninvasive molecular diagnostic techniques are not only the latest cutting-edge technique to help clinicians improve disease prognosis—they are proving to be an essential element for the continued ...
(Provista Diagnostics) A Clinical Breast Cancer study demonstrates Videssa Breast can inform better next steps after abnormal mammogram results and potentially reduce biopsies up to 67 percent.
A new study has demonstrated that a multi-protein biomarker blood test to identify breast cancer can potentially reduce use of biopsy by up to 67% in women under the age of 50.
A University of Oklahoma and Mercy Hospital Oklahoma City research team is set to begin the largest breast cancer clinical trial ever performed in Oklahoma. The team has developed new breast cancer ri...
A genetic test that helps doctors determine how best to treat breast cancer-;and whether chemotherapy is likely to help- is significantly more likely to be administered to white women than blacks or H...
To report early outcome analysis of a prospective institutional phase 2 trial of weekly hypofractionated breast irradiation (WHBI) for patients undergoing breast-conserving surgery (BCS).
SUPREMO is a phase 3 randomised trial evaluating radiotherapy post-mastectomy for intermediate-risk breast cancer. 1688 patients were enrolled from 16 countries between 2006 and 2013. We report the re...
We aim to assess any association between study and self-reported conflict of interest (COI) or trial sponsorship in breast cancer radiation clinical trials.
This study examines the accuracy of the Test of Memory Malingering (TOMM), a frequently administered measure for evaluating effort during neurocognitive testing. In the last few years, several authors...
There is increasing interest in combining postmenopausal hormone therapy (HT) and SERMs in midlife women. We previously showed that refusal to participate in a prevention trial of low dose tamoxifen i...